Test Bank For Pharmacology Clear and Simple:
| | | | | | |
A Guide to Drug Classifications and Dosage Calculations,
| | | | | | | |
4th Edition by Cynthia J. Watkins
| | | | | |
Chapters 1 - 21
| | | |
,
,Chapter |1. |History |of | Pharmacology
Pharmacology |Clear |and |Simple- |A |Guide |to |Drug |Classifications |and |Dosage |Calculations |4th
|Edition |Watkins |Test |Bank
1. A |nurse | working | in |radiology |administers | iodine | to |a | patient | who |is | having | a |computed
|tomography | (CT) | scan. | The | nurse | working | on | the | oncology | unit |administers
|chemotherapy | to | patients | who | have | cancer. | At | the | Public | Health |Department, | a | nurse
|administers | a | measles-mumps-rubella | (MMR) | vaccine |to |a | 14-month-old |child | as | a
|routine | immunization. | Which |branch | of |pharmacology |best | describes |the |actions |of |all
|three |nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology |is |the | study |of |the | biologic |effects |of |chemicals. | Nurses |are |involved
|with | clinical | pharmacology | or | pharmacotherapeutics, | which | is | a |branch | of
|pharmacology | that | deals | with | the | uses | of | drugs | to | treat, | prevent, |and | diagnose | disease.
|The | radiology | nurse | is | administering | a | drug | to | help |diagnose | a | disease. | The | oncology
|nurse | is | administering | a | drug | to | help | treat |a | disease. | Pharmacoeconomics | includes | any
|costs | involved | in | drug | therapy. |Pharmacodynamics | involves |how |a | drug |affects | the
|body |and |pharmacokinetics |is |how |the |body |acts |on |the |body.
2. A |physician |has |ordered |intramuscular |(IM) |injections |of |morphine, |a
|narcotic, | every |4 | hours | as | needed | for | pain |in |a | motor | vehicle | accident
|victim. | The | nurse | is | aware | this | drug | has | a | high | abuse | potential. | Under | what
|category |would |morphine |be |classified?
A) Schedule |I
B) Schedule |II
C) Schedule |III
D) Schedule |IV
ANSWER: B
, Feedback:
Narcotics |with |a |high |abuse |potential |are |classified |as |Schedule |II |drugs
|because | of | severe | dependence | liability. | Schedule | I |drugs | have | high | abuse
|potential | and | no | accepted | medical | use. | Schedule | III | drugs | have | a | lesser
|abuse | potential | than | II | and | an | accepted | medical | use. | Schedule | IV | drugs | have
|low |abuse |potential |and |limited | dependence |liability.
3. When | involved | in | phase | III | drug | evaluation | studies, | what | responsibilities
|would |the |nurse |have?
A) Working |with | animals | who | are | given | experimental | drugs
B) Choosing | appropriate | patients | to |be | involved | in | the |drug |study
C) Monitoring |and | observing |patients | closely | for | adverse | effects
D) Conducting | research | to | determine | effectiveness | of | the | drug
ANSWER: C
Feedback:
Phase | III |studies |involve | use |of |a | drug |in | a |vast | clinical | population |in |which
|patients | are | asked | to | record | any | symptoms | they | experience | while | taking | the
|drugs. | Nurses | may |be | responsible | for | helping | collect | and |analyze | the
|information | to | be | shared | with | the | Food | and | Drug | Administration | (FDA) | but
|would | not | conduct | research | independently | because | nurses | do | not | prescribe
|medications. | Use | of | animals | in | drug | testing | is | done | in | the | preclinical | trials.
|Select | patients | who | are | involved | in | phase | II | studies | to | participate | in | studies
|where | the | participants | have | the | disease | the | drug | is | intended | to | treat. | These
|patients | are | monitored | closely | for | drug | action | and | adverse | effects. | Phase | I
|studies | involve | healthy | human | volunteers | who | are | usually |paid | for | their
|participation. | Nurses |may |observe | for | adverse | effects | and |toxicity.
4. What | concept | is |considered | when | generic | drugs | are | substituted | for | brand
|name |drugs?
A) Bioavailability
B) Critical | concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback:
| | | | | | |
A Guide to Drug Classifications and Dosage Calculations,
| | | | | | | |
4th Edition by Cynthia J. Watkins
| | | | | |
Chapters 1 - 21
| | | |
,
,Chapter |1. |History |of | Pharmacology
Pharmacology |Clear |and |Simple- |A |Guide |to |Drug |Classifications |and |Dosage |Calculations |4th
|Edition |Watkins |Test |Bank
1. A |nurse | working | in |radiology |administers | iodine | to |a | patient | who |is | having | a |computed
|tomography | (CT) | scan. | The | nurse | working | on | the | oncology | unit |administers
|chemotherapy | to | patients | who | have | cancer. | At | the | Public | Health |Department, | a | nurse
|administers | a | measles-mumps-rubella | (MMR) | vaccine |to |a | 14-month-old |child | as | a
|routine | immunization. | Which |branch | of |pharmacology |best | describes |the |actions |of |all
|three |nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology |is |the | study |of |the | biologic |effects |of |chemicals. | Nurses |are |involved
|with | clinical | pharmacology | or | pharmacotherapeutics, | which | is | a |branch | of
|pharmacology | that | deals | with | the | uses | of | drugs | to | treat, | prevent, |and | diagnose | disease.
|The | radiology | nurse | is | administering | a | drug | to | help |diagnose | a | disease. | The | oncology
|nurse | is | administering | a | drug | to | help | treat |a | disease. | Pharmacoeconomics | includes | any
|costs | involved | in | drug | therapy. |Pharmacodynamics | involves |how |a | drug |affects | the
|body |and |pharmacokinetics |is |how |the |body |acts |on |the |body.
2. A |physician |has |ordered |intramuscular |(IM) |injections |of |morphine, |a
|narcotic, | every |4 | hours | as | needed | for | pain |in |a | motor | vehicle | accident
|victim. | The | nurse | is | aware | this | drug | has | a | high | abuse | potential. | Under | what
|category |would |morphine |be |classified?
A) Schedule |I
B) Schedule |II
C) Schedule |III
D) Schedule |IV
ANSWER: B
, Feedback:
Narcotics |with |a |high |abuse |potential |are |classified |as |Schedule |II |drugs
|because | of | severe | dependence | liability. | Schedule | I |drugs | have | high | abuse
|potential | and | no | accepted | medical | use. | Schedule | III | drugs | have | a | lesser
|abuse | potential | than | II | and | an | accepted | medical | use. | Schedule | IV | drugs | have
|low |abuse |potential |and |limited | dependence |liability.
3. When | involved | in | phase | III | drug | evaluation | studies, | what | responsibilities
|would |the |nurse |have?
A) Working |with | animals | who | are | given | experimental | drugs
B) Choosing | appropriate | patients | to |be | involved | in | the |drug |study
C) Monitoring |and | observing |patients | closely | for | adverse | effects
D) Conducting | research | to | determine | effectiveness | of | the | drug
ANSWER: C
Feedback:
Phase | III |studies |involve | use |of |a | drug |in | a |vast | clinical | population |in |which
|patients | are | asked | to | record | any | symptoms | they | experience | while | taking | the
|drugs. | Nurses | may |be | responsible | for | helping | collect | and |analyze | the
|information | to | be | shared | with | the | Food | and | Drug | Administration | (FDA) | but
|would | not | conduct | research | independently | because | nurses | do | not | prescribe
|medications. | Use | of | animals | in | drug | testing | is | done | in | the | preclinical | trials.
|Select | patients | who | are | involved | in | phase | II | studies | to | participate | in | studies
|where | the | participants | have | the | disease | the | drug | is | intended | to | treat. | These
|patients | are | monitored | closely | for | drug | action | and | adverse | effects. | Phase | I
|studies | involve | healthy | human | volunteers | who | are | usually |paid | for | their
|participation. | Nurses |may |observe | for | adverse | effects | and |toxicity.
4. What | concept | is |considered | when | generic | drugs | are | substituted | for | brand
|name |drugs?
A) Bioavailability
B) Critical | concentration
C) Distribution
D) Half-life
ANSWER: A
Feedback:
